Standout Papers

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results o... 2006 2026 2012 2019 618
  1. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine (2006)
    Norbert Müller, Markus Schwarz et al. Molecular Psychiatry

Immediate Impact

3 by Nobel laureates 26 from Science/Nature 140 standout
Sub-graph 1 of 20

Citing Papers

Transforming the understanding of brain immunity
2023 StandoutScience
Single-cell eQTL mapping identifies cell type–specific genetic control of autoimmune disease
2022 StandoutScience
8 intermediate papers

Works of Volker Arolt being referenced

Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease
2017
S100B in brain damage and neurodegeneration
2003
and 6 more

Author Peers

Author Last Decade Papers Cites
Volker Arolt 2517 2581 2065 3304 248 11.7k
Shigenobu Kanba 2519 3291 1494 2308 316 13.6k
Anthony J. Cleare 2094 3204 1818 2708 211 11.0k
Isabella Heuser 2416 3532 1748 1852 295 12.2k
Owen M. Wolkowitz 1330 1744 971 2815 218 13.4k
Günter Kenis 1081 2015 898 3312 146 10.6k
Thomas Frodl 5799 3393 1486 2004 233 12.2k
Linda L. Carpenter 2396 2549 1359 1810 236 13.6k
Elisa Brietzke 965 4160 1128 4223 269 11.6k
Witte J.G. Hoogendijk 1303 1696 2033 2675 200 11.4k
Katharina Domschke 2748 2151 2571 1462 366 10.9k

All Works

Loading papers...

Rankless by CCL
2026